US Bancorp’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-289,250
Closed -$23.2M 3740
2016
Q4
$23.2M Sell
289,250
-6,683
-2% -$530K 0.08% 194
2016
Q3
$23.6M Sell
295,933
-16,206
-5% -$1.31M 0.09% 195
2016
Q2
$24.3M Buy
312,139
+24,750
+9% +$1.76M 0.09% 186
2016
Q1
$15.8M Buy
287,389
+40,710
+17% +$2.22M 0.06% 249
2015
Q4
$15.2M Sell
246,679
-1,056
-0.4% -$66.6K 0.06% 253
2015
Q3
$15.6M Sell
247,735
-33
-0% -$2.35K 0.07% 242
2015
Q2
$18.1M Sell
247,768
-2,024
-0.8% -$146K 0.07% 232
2015
Q1
$16.3M Buy
249,792
+430
+0.2% +$28.6K 0.06% 249
2014
Q4
$16.2M Buy
249,362
+542
+0.2% +$34.9K 0.06% 249
2014
Q3
$15M Sell
248,820
-2,051
-0.8% -$134K 0.06% 244
2014
Q2
$17.4M Sell
250,871
-41,052
-14% -$2.66M 0.07% 223
2014
Q1
$19.1M Sell
291,923
-14,712
-5% -$958K 0.08% 198
2013
Q4
$19M Buy
306,635
+39,979
+15% +$2.32M 0.08% 200
2013
Q3
$14.3M Sell
266,656
-1,298
-0.5% -$66.8K 0.06% 232
2013
Q2
$12.2M Buy
+267,954
New +$11.6M 0.06% 248

Other funds holding STJ

US Bancorp's STJ Position: Q1 2017 in Review

US Bancorp sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 289,250 shares — an estimated $23.2M sold.

US Bancorp first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $24.3M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • US Bancorp reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • US Bancorp sold 289,250 St Jude Medical shares in Q1 2017, an estimated $23.2M.
  • US Bancorp first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • US Bancorp's St Jude Medical position peaked at $24.3M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.